Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Treasury Shares (2016 - 2026)

Champions Oncology has reported Treasury Shares over the past 12 years, most recently at $708000.0 for Q1 2026.

  • For Q1 2026, Treasury Shares changed 0.0% year-over-year to $708000.0; the TTM value through Jan 2026 reached $708000.0, changed 0.0%, while the annual FY2025 figure was $708000.0, 0.0% changed from the prior year.
  • Treasury Shares for Q1 2026 was $120333.0 at Champions Oncology, roughly flat from $120333.0 in the prior quarter.
  • Over five years, Treasury Shares peaked at $120333.0 in Q1 2024 and troughed at $4896.0 in Q4 2023.
  • A 4-year average of $101479.3 and a median of $120333.0 in 2024 define the central range for Treasury Shares.
  • On a YoY basis, Treasury Shares climbed as much as 856.76% in 2024 and fell as far as 0.0% in 2024.
  • Year by year, Treasury Shares stood at $708000.0 in 2023, then changed by 0.0% to $708000.0 in 2024, then changed by 0.0% to $708000.0 in 2025, then changed by 0.0% to $708000.0 in 2026.
  • Business Quant data shows Treasury Shares for CSBR at $708000.0 in Q1 2026, $708000.0 in Q4 2025, and $708000.0 in Q3 2025.